Clinical Infectious Diseases · 2014 · 34 citations · 27 references
Life SciencesImmunologyInfectious DiseasesImmunizationMolecular VirologyVirologyVaccinationVaccine-preventable DiseasesViral GenomicsViral InfectionsViral VaccinesAcute Flaccid Paralysis SurveillanceInactivated Polio VaccineOral Polio VaccinationPoliovirus SurveillancePoliovirus VaccinationPoliovirus VaccinesTransgenic Mouse ModelsVaccine Characterization
BACKGROUND: Israel has >95% polio vaccine coverage with the last 9 birth cohorts immunized exclusively with inactivated polio vaccine (IPV). Using acute flaccid paralysis and routine, monthly countrywide environmental surveillance, no wild poliovirus circulation was detected between 1989 and February 2013, after which wild type 1 polioviruses South Asia genotype (WPV1-SOAS) have persistently circulated in southern Israel and intermittently in other areas without any paralytic cases as determined by intensified surveillance of environmental and human samples. We aimed to characterize antigenic and neurovirulence properties of WPV1-SOAS silently circulating in a highly vaccinated population. METHODS: WPV1-SOAS capsid genes from environmental and stool surveillance isolates were sequenced, their neurovirulence was determined using transgenic mouse expressing the human poliovirus receptor (Tg21-PVR) mice, and their antigenicity was characterized by in vitro neutralization using human sera, epitope-specific monoclonal murine anti-oral poliovirus vaccine (OPV) antibodies, and sera from IPV-immunized rats and mice. RESULTS: WPV1 amino acid sequences in neutralizing epitopes varied from Sabin 1 and Mahoney, with little variation among WPV1 isolates. Neutralization by monoclonal antibodies against 3 of 4 OPV epitopes was lost. Three-fold lower geometric mean titers (Z = -4.018; P < .001, Wilcoxon signed-rank test) against WPV1 than against Mahoney in human serum correlated with 4- to 6-fold lower neutralization titers in serum from IPV-immunized rats and mice. WPV1-SOAS isolates were neurovirulent (50% intramuscular paralytic dose in Tg21-PVR mice: log10(7.0)). IPV-immunized mice were protected against WPV1-induced paralysis. CONCLUSIONS: Phenotypic and antigenic profile changes of WPV1-SOAS may have contributed to the intense silent transmission, whereas the reduced neurovirulence may have contributed to the absence of paralytic cases in the background of high population immunity.
27
Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993
Chen-Fu Yang, Tary Naguib, Su-Ju Yang et al. · Journal of Virology · 2003 · 236 citations · Full text
BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIA
C. Vermylen, J. Ninane, E. Fernandez Robles et al. · The Lancet · 1988 · 195 citations
Medicine, Hematology, Pediatrics +10
Y. Manor, Rachel Handsher, T. Halmut et al. · Journal of Clinical Microbiology · 1999 · 176 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +15